RAPT Therapeutics, Inc. (RAPT:NASDAQ) closed at $58.02 on March 2, 2026, unchanged on the day. It is trading at its 52-week high of $58.02. RAPT Therapeutics, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 22, 2025, RAPT closed higher on 49 days (19%). Its best day was January 20, 2026 (+64.02%) and its worst was October 22, 2025 (-10.53%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases.
Find more stocks like RAPT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.